Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises IBT on rights offering
Mandate

Vinge advises IBT on rights offering

April 28, 2016

Infant Bacterial Therapeutics AB (publ) (IBT) carries out a rights offering of SEK 100 million. Vinge advises IBT.

The Vinge team primarily consists of Erik Sjöman and Dain Hård Nevonen (partners, capital markets & public M&A) and associates Ludvig Frithiof, Joel Wahlberg and Astrid Karlsson, and Tora Hansjons (tax).

Related

Vinge advises Precise Biometrics in connection with rights issue
July 24, 2026

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

 Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

 Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026